PL2413952T3 - Polepszenie promowania zdrowego doganiania wzrostu - Google Patents

Polepszenie promowania zdrowego doganiania wzrostu

Info

Publication number
PL2413952T3
PL2413952T3 PL10710358T PL10710358T PL2413952T3 PL 2413952 T3 PL2413952 T3 PL 2413952T3 PL 10710358 T PL10710358 T PL 10710358T PL 10710358 T PL10710358 T PL 10710358T PL 2413952 T3 PL2413952 T3 PL 2413952T3
Authority
PL
Poland
Prior art keywords
promotion
growth
improvement
catch
healthy
Prior art date
Application number
PL10710358T
Other languages
English (en)
Inventor
Olivier Aprikian
Florence Blancher
Catherine Mace
Yassaman Shahkhalili
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40802132&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2413952(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of PL2413952T3 publication Critical patent/PL2413952T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10710358T 2009-04-03 2010-03-26 Polepszenie promowania zdrowego doganiania wzrostu PL2413952T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09157244 2009-04-03
EP10710358.2A EP2413952B2 (en) 2009-04-03 2010-03-26 Improvement in promotion of healthy catch-up growth

Publications (1)

Publication Number Publication Date
PL2413952T3 true PL2413952T3 (pl) 2017-08-31

Family

ID=40802132

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10710358T PL2413952T3 (pl) 2009-04-03 2010-03-26 Polepszenie promowania zdrowego doganiania wzrostu

Country Status (15)

Country Link
US (1) US8846612B2 (pl)
EP (1) EP2413952B2 (pl)
CN (1) CN102378632A (pl)
AU (1) AU2010230283B2 (pl)
BR (1) BRPI1014065A2 (pl)
CA (1) CA2755860A1 (pl)
CL (1) CL2011002465A1 (pl)
ES (1) ES2570461T5 (pl)
MX (1) MX2011010454A (pl)
MY (1) MY183275A (pl)
PL (1) PL2413952T3 (pl)
RU (1) RU2011144581A (pl)
SG (1) SG174355A1 (pl)
TW (1) TW201039754A (pl)
WO (1) WO2010112430A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2514435A1 (en) * 2011-04-19 2012-10-24 Nestec S.A. Infant formula for use in the prevention of cardiovascular diseases
US10039296B2 (en) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Probiotic compositions and methods
EP3718410A1 (en) 2012-03-12 2020-10-07 N.V. Nutricia Process for the humanization of animal skim milk and products obtained thereby
SE1251123A1 (sv) * 2012-10-05 2014-04-06 Indevex Ab Publ Födoämnesprodukt
CA2911496C (en) 2013-05-10 2023-08-22 H.J. Heinz Company Brands Llc Probiotics and methods of use
WO2015041515A1 (en) * 2013-09-19 2015-03-26 N.V. Nutricia Improved process for the humanization of animal skim milk
WO2015078938A1 (en) 2013-11-29 2015-06-04 Nestec S.A. Age-tailored nutritional compositions with a varying protein content
AU2014356485A1 (en) * 2013-11-29 2016-03-03 Nestec S.A. Infant nutrition for improvement in insulin sensitivity later in life
WO2015178762A1 (en) * 2014-05-19 2015-11-26 N.V. Nutricia Enteral formulations for preterm infants comprising optimised phenylalanine intake levels
CN106659227B (zh) * 2014-05-19 2022-02-11 N·V·努特里奇亚 包含优化的氨基酸谱的配方物
JP6760931B2 (ja) * 2014-11-19 2020-09-23 ソシエテ・デ・プロデュイ・ネスレ・エス・アー インスリン特性を改善するためのホエイタンパク質ミセル及び多糖類の使用
RS62368B1 (sr) 2015-05-22 2021-10-29 Univ Leland Stanford Junior Lečenje postbarijatrijske hipoglikemije eksendinom(9-39)
US20160353775A1 (en) * 2015-06-04 2016-12-08 Balchem Corporation Hydration Control for Choline Salts
WO2017152014A1 (en) 2016-03-04 2017-09-08 Eiger Biopharmaceuticals, Inc. Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
AU2017361539B2 (en) 2016-11-21 2023-06-29 Eiger Biopharmaceuticals, Inc. Buffered formulations of exendin (9-39)
CN110267549A (zh) 2017-02-20 2019-09-20 雀巢产品有限公司 具有部分水解的蛋白质的用于诱导接近于用人乳观察到的葡萄糖和/或胰岛素反应的葡萄糖和/或胰岛素反应的营养组合物
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
EP4190324A4 (en) * 2020-07-31 2024-08-14 Otsuka Pharma Factory Inc NUTRITIONAL FORMULATION
WO2024025934A1 (en) * 2022-07-29 2024-02-01 Abbott Laboratories Methods for promoting healthy catch-up growth

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9708656A (pt) * 1996-04-12 2000-01-04 Beth Israel Hospital Barra suplementar para diabéticos
AUPO272196A0 (en) * 1996-10-02 1996-10-24 Horton, David Robert Filtration apparatus
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
EP1196047A4 (en) 1999-06-29 2004-12-22 New Zealand Milk Inst Ltd MILK-BASED PROPHYLACTIC FOOD SUPPLEMENTS
CA2444470A1 (en) 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
IL208378A0 (en) † 2003-02-10 2011-07-31 Univ London An infant feeding formula and use thereof
JP2007525404A (ja) * 2003-08-30 2007-09-06 ネステク ソシエテ アノニム ミセルカゼインの酸可溶性蛋白質
MXPA06010014A (es) 2004-03-01 2007-03-07 Peptera Pharmaceuticals Ltd Peptidos derivados de la caseina y usos terapeuticos de los mismos.
CN101212911B (zh) * 2005-07-01 2012-12-05 努特里希亚公司 含水解的蛋白质的婴儿营养品
PL1940248T3 (pl) 2005-10-05 2010-05-31 Nestec Sa Zastosowanie odżywczej formulacji do promowania doganiania wzrostu
WO2008054192A1 (en) † 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
DE602007008062D1 (de) * 2006-01-31 2010-09-09 Nestec Sa Nährstoffzusammensetzung für säuglinge mit niedrigem geburtsgewicht
DE102006052560B4 (de) 2006-11-06 2010-01-21 Humana Milchunion Eg Anti-diabetogene Calcium-Peptid-Zusammensetzung
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula

Also Published As

Publication number Publication date
EP2413952B1 (en) 2016-03-23
SG174355A1 (en) 2011-10-28
ES2570461T5 (es) 2020-04-03
MX2011010454A (es) 2012-01-25
CL2011002465A1 (es) 2012-03-23
EP2413952B2 (en) 2019-10-02
RU2011144581A (ru) 2013-05-10
TW201039754A (en) 2010-11-16
BRPI1014065A2 (pt) 2016-04-12
EP2413952A1 (en) 2012-02-08
CA2755860A1 (en) 2010-10-07
AU2010230283B2 (en) 2015-02-05
AU2010230283A1 (en) 2011-10-13
US8846612B2 (en) 2014-09-30
CN102378632A (zh) 2012-03-14
MY183275A (en) 2021-02-18
US20120021977A1 (en) 2012-01-26
ES2570461T3 (es) 2016-05-18
WO2010112430A1 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
PL2413952T3 (pl) Polepszenie promowania zdrowego doganiania wzrostu
PL2424621T3 (pl) Sposoby poprawy smaku i kompozycji do higieny jamy ustnej o ulepszonym smaku
HK1161841A1 (en) Nutritional composition to promote healthy development and growth
IL215393A0 (en) Therapy for promoting cell growth
EP2393364A4 (en) TREATMENT OF LUNG CANCER WITH A PARP INHIBITOR IN COMBINATION WITH A GROWTH FACTOR INHIBITOR
IL216128A (en) Antibodies to ngf with increased in vivo stability
HK1167903A1 (en) Wristwatch
EP2438246A4 (en) CONSTRUCTION ASPECTS
IL218212A0 (en) Therapeutic methods and compositions
ZA201105384B (en) To be advised
EP2484355A4 (en) ACCELERATION COMPOSITION FOR PRODUCTION OF LAMININ-332
EP2506840A4 (en) USE OF HYPOXIA-INDUCED FACTOR INHIBITORS
ZA201202213B (en) Treatment of minerals
GB0902537D0 (en) Improvememts in or relating to the creation of curved forms
GB2472663B (en) Improvements in or relating to undercup insert members
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
HRP20131121T1 (hr) Postupak za poboljšanje neprozirnosti
EP2501803A4 (en) PROCESS FOR PLURIPOTENZINTENSIVATION
GB2475489B (en) Improvements in or relating to toothbrushes
GB0919985D0 (en) Treatment of grain
GB0910993D0 (en) Improvements in or relating to the creation of curved forms
GB0902539D0 (en) Improvements in or relating to the creation of curved forms
GB0910995D0 (en) Improvements in or relating to the creation of curved forms
TWM373691U (en) Improved structure of chair
HU0900664D0 (en) Healthier smoking